{"id":16375,"date":"2026-06-19T08:39:50","date_gmt":"2026-06-19T05:39:50","guid":{"rendered":"https:\/\/nesiller.com\/miyeloproliferatif-neoplaziler-mpn-paneli\/"},"modified":"2026-10-26T14:48:11","modified_gmt":"2026-10-26T11:48:11","slug":"myeloproliferative-neoplasms-mpn-panel","status":"publish","type":"page","link":"https:\/\/nesiller.com\/en\/oncology\/focus-hematology-panels\/myeloproliferative-neoplasms-mpn-panel\/","title":{"rendered":"Myeloproliferative Neoplasms (MPN) Panel"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"16375\" class=\"elementor elementor-16375\" data-elementor-post-type=\"page\">\n\t\t\t\t<div data-ekitparallax=\"{&quot;ekit_section_parallax_bg&quot;:&quot;yes&quot;,&quot;ekit_section_parallax_bg_speed&quot;:0.5,&quot;elementor_lazy_load&quot;:&quot;1&quot;}\" class=\"elementor-element elementor-element-f1458fc e-flex e-con-boxed e-con e-parent\" data-id=\"f1458fc\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-a7a8da6 e-con-full e-flex e-con e-child\" data-id=\"a7a8da6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1e8dbf4 section-title at-heading-animation at-animation-heading-none elementor-invisible elementor-widget elementor-widget-heading\" data-id=\"1e8dbf4\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInUp&quot;,&quot;ekit_we_effect_on&quot;:&quot;none&quot;}\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\"><a href=\"https:\/\/nesiller.com\/en\/oncology\/focus-hematology-panels\/\">FOCUS Hematology Panels<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-88e9e06 elementor-widget elementor-widget-heading\" data-id=\"88e9e06\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;ekit_we_effect_on&quot;:&quot;none&quot;}\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Myeloproliferative Neoplasms (MPN) Panel<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-29319d5 e-flex e-con-boxed e-con e-parent\" data-id=\"29319d5\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-315b981 elementor-widget elementor-widget-text-editor\" data-id=\"315b981\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;ekit_we_effect_on&quot;:&quot;none&quot;}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>Myeloproliferative Neoplasms (MPNs)<\/strong> are a group of hematological disorders characterized by the abnormal proliferation of blood-forming cells in the bone marrow. These disorders may lead to increased production of red blood cells, white blood cells, or platelets, disrupting the balance of blood cells. Genetic changes, such as alterations in the JAK2 gene, and specific chromosomal rearrangements may play a role in the development of MPNs. Identifying these genetic and chromosomal abnormalities can help classify the disease and distinguish it from other hematological disorders.<\/p>\n<p>MPN treatment is planned according to the disease subtype, risk level, symptoms, and the patient&#8217;s overall health. Treatment options may include medications that control blood cell production, targeted therapies, and supportive care when needed. Genetic and chromosomal analyses can help characterize the disease and support clinical decision-making.<\/p>\n<table border=\"0\" width=\"195\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr style=\"height: 29.0pt;\">\n<td class=\"xl66\" style=\"height: 29.0pt; width: 49pt;\" width=\"65\" height=\"39\"><strong>Genetic Alterations<\/strong><\/td>\n<td class=\"xl66\" style=\"width: 49pt;\" width=\"65\"><strong>Method<\/strong><\/td>\n<td class=\"xl66\" style=\"width: 49pt;\" width=\"65\"><strong>Sample Type<\/strong><\/td>\n<\/tr>\n<tr style=\"height: 72.5pt;\">\n<td class=\"xl65\" style=\"height: 72.5pt; width: 49pt;\" width=\"65\" height=\"97\">CHIC2 deletion<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<tr style=\"height: 72.5pt;\">\n<td class=\"xl65\" style=\"height: 72.5pt; width: 49pt;\" width=\"65\" height=\"97\">FGFR1 (8p12) rearrangement<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<tr style=\"height: 58.0pt;\">\n<td class=\"xl65\" style=\"height: 58.0pt; width: 49pt;\" width=\"65\" height=\"77\">PDGFRB (5q33.1) rearrangement<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<tr style=\"height: 72.5pt;\">\n<td class=\"xl65\" style=\"height: 72.5pt; width: 49pt;\" width=\"65\" height=\"97\">t(9;22) &amp; variants<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<tr style=\"height: 72.5pt;\">\n<td class=\"xl65\" style=\"height: 72.5pt; width: 49pt;\" width=\"65\" height=\"97\">JAK2 (9p24) rearrangement<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<tr style=\"height: 87.0pt;\">\n<td class=\"xl65\" style=\"height: 87.0pt; width: 49pt;\" width=\"65\" height=\"116\">(12p13) rearrangement<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<tr style=\"height: 72.5pt;\">\n<td class=\"xl65\" style=\"height: 72.5pt; width: 49pt;\" width=\"65\" height=\"97\">Monosomy 7 ve 7q deletion<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<tr style=\"height: 58.0pt;\">\n<td class=\"xl65\" style=\"height: 58.0pt; width: 49pt;\" width=\"65\" height=\"77\">Trisomy 8<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">FISH<\/td>\n<td class=\"xl65\" style=\"width: 49pt;\" width=\"65\">Bone Marrow \/ Heparinized Blood<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b9b48fb elementor-widget elementor-widget-text-editor\" data-id=\"b9b48fb\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;ekit_we_effect_on&quot;:&quot;none&quot;}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>FOCUS Myeloproliferative Neoplasms (MPN) Panel analyzes CHIC2 deletion, FGFR1, PDGFRB and JAK2 rearrangements, t(9;22), monosomy 7\/7q deletion and trisomy 8 by FISH in bone marrow or heparinized blood.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":16386,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-16375","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/16375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/comments?post=16375"}],"version-history":[{"count":25,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/16375\/revisions"}],"predecessor-version":[{"id":22046,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/16375\/revisions\/22046"}],"up":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/16386"}],"wp:attachment":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/media?parent=16375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}